Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids

Chemistry Central Journal

Volumn 5, Issue 1, 2011, Pages

  Walash, Mohamed I ^a   Belal, Fathallah F ^a   El Enany, Nahed M ^a   Elmansi, Heba ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053904401     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-5-61     Document Type: Article

References (28)

1. Nickell PV, Ward HE, Booth RG. Antianxiety agents. Burger's Medicinal Chemistry and Drug Discovery 1997, 5:153-194. John Wiley and Sons, New York, Wolff ME.
2. The British Pharmacopoeia 2009. 2009, The stationary office: London, Electronic version.
3. Onal A, Kepekci SE, Cetin SM, Ertürk S. Spectrophotometric determination of certain antidepressants in pharmaceutical preparations. J AOAC Int 2006, 89:966-971.
4. Darwish IA. Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline and paroxetine in pharmaceutical dosage forms. J AOAC Int 2005, 88:38-45.
5. Parasrampuria J. Sertraline hydrochloride. Analytical Profiles of Drug Substances and Excipients 1996, 24:443-486. Academic Press: New York, Brittain HG.
6. Rogowsky D, Marr M, Long G, Moore C. Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr Biomed Appl 1994, 655:138-141.
7. Logan BK, Friel PN, Case GA. Analysis of sertraline (Zoloft) and its major metabolite in post-mortem specimens by gas and liquid chromatography. J Anal Toxicol 1994, 18:139-142.
8. Fouda HG, Ronfeld RA, Weidler DJ. Gas-chromatographic - mass-spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drug. J Chromatogr Biomed Appl 1987, 61:197-202.
9. Tremaine LM, Joerg EA. Automated gas-chromatographic - electron-capture assay for the selective serotonin uptake-blocker, sertraline. J Chromatogr Biomed Appl 1989, 88:423-429.
10. Gupta RN, Dziurdzy SA. Therapeutic monitoring of sertraline. Clin Chem 1994, 40:498-499.
11. Wiener HL, Kramer HK, Reith MEA. Separation and determination of sertraline and its metabolite, demethylsertraline, in mouse cerebral cortex by reversed-phase high-performance liquid chromatography. J Chromatogr Biomed Appl 1990, 92:467-472.
12. Patel J, Spencer EP, Flangan RJ. HPLC of sertraline and norsertraline in plasma or serum. Biomed Chromtogr 1990, 10:351-354.
13. McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline, and pimozide. J Forensic Sci 1997, 42:951-953.
14. El-Emam AA, Hansen SH, Moustafa MA, El-Ashry SM, El-Sherbiny DT. Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-C1) followed by spectrophotometry or HPLC with fluorimetric detection. J Pharm Biomed Anal 2004, 34:35-44. 10.1016/j.japna.2003.08.021, 14738917.
15. El-Enany N. Spectrofluorimetric and spectrophotometric determination of gliclazide in pharmaceuticals by derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole. J AOAC Int 2003, 86:209-214.
16. El-Enany N, Belal F, Rizk M. Kinetic spectrophotometric determination of isoxsuprine in dosage forms through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). Sci Pharm 2006, 74:99-119.
17. El-Enany N, El-Sherbiny D, Belal F. Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma. Chem Pharm Bull 2007, 55:1662-70. 10.1248/cpb.55.1662, 18057737.
18. Ulu ST. Determination of tianeptine in human plasma using high-performance liquid chromatography with fluorescence detection. J Chromatogr B 2006, 834:62-67.
19. Erturk S, Cetin SM, Atmaca S, Ersoy L, Baktr G. A sensitive HPLC method for the determination of Fluoxetine and Norfluoxetine in human plasma with fluorescence detection. Ther Drug Monit 2005, 27:38-43. 10.1097/00007691-200502000-00009, 15665745.
20. Farshchia A, Ghiasi G, Bahrami G. High performance liquid chromatography determination of sertraline in human. Iranian Journal of Pharmaceutical Sciences 2009, 5:171-178.
21. Mahmoud AM, Darwish IA, Khalil NY. Fluorimetric study for the reaction between sertraline and 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: kinetics, mechanism and application for the determination of sertraline in tablets. J Fluorescence 2010, 20:607-13.
22. ICH Harmonized Tripartite Guideline Validation of Analytical Procedures. 2005, Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology , ICH Harmonized Tripartite Guideline., http://www.bioforum.org.il/Uploads/Editor/karen/q2_r1_step4.pdf
23. Malfará WR, Bertucci C, Costa Queiroz ME, Dreossi Carvalho SA, Pires Bianchi Mde L, Cesarino EJ, Crippa JA, Costa Queiroz RH. Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. J Pharm Biomed Anal 2007, 44:955-962. 10.1016/j.jpba.2007.04.005, 17512687.
24. Miyano H, Toyo'oka T, Miyano H. Further studies on the reaction of amines and proteins with 4-fluoro-7-nitrobenzofurazan. Anal Chim Acta 1985, 170:81-87.
25. Miller JN, Miller JC. Statistics and chemometrics for analytical chemistry 2005, 39-73. Prentice Hall: England, 5.
26. Kim KM, Jung BH, Choi MH, Woo JS, Paeng KJ, Chung BC. Rapid and sensitive determination of sertraline in human plasma using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 769:333-339. 10.1016/S1570-0232(02)00027-2, 11996499.
27. Rose J. Advanced physico-chemical experiments 1964, Pitman: London, England.
28. Bartlett MG, Spell JC, Mathis PS, Elgany MF, El Zeany BE, Elkawy MA, Stewart JT. Determination of degradation products from the calcium-channel blocker isradipine. J Pharm Biomed Anal 1998, 18:335-345. 10.1016/S0731-7085(98)00047-8, 10096828.